𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk factors for tumor occurrence in patients with myasthenia gravis

✍ Scribed by Antonietta Citterio; Ettore Beghi; Andrea Millul; Amelia Evoli; Renato Mantegazza; Carlo Antozzi; Fulvio Baggi; Ferdinando Cornelio; Luca Durelli; Marinella Clerico; Giovanni Piccolo; Vittorio Cosi

Publisher
Springer
Year
2009
Tongue
English
Weight
208 KB
Volume
256
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cholinergic neuromuscular hyperactivity
Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody
✍ Anna Rostedt Punga; Roland Flink; HΓ₯kan Askmark; Erik V. StΓ₯lberg πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 151 KB

## Abstract A 75‐year‐old man with severe oculobulbar myasthenia gravis (MG) treated with acetylcholine esterase inhibitors (AChEIs) was found to have muscle‐specific tyrosine kinase (MuSK) antibodies. Neurophysiological examination displayed extra repetitive discharges after the compound motor act

MRI of the mediastinum for detection of
MRI of the mediastinum for detection of thymoma in patients with myasthenia gravis
✍ Poonam Batra; Christian Herrman; John Keesey; Donald Mulder πŸ“‚ Article πŸ“… 1986 πŸ› Elsevier Science 🌐 English βš– 101 KB

CT plays an important role in the diagnosis and staging of musculoskeletal tumors, but MRI offers several significant advantages. MRI can provide superior soft tissue and marrow contrast and direct multiplanar images are routinely obtainable. Previous MRI studies have utilized low field strength m